KEMET Reports Fourth Quarter and Fiscal Year 2011 Financial Results
-Net sales of $261.5 million for the March 2011 quarter up 22.8% compared to prior year fourth quarter
-Net sales of $1.018 billion for the fiscal year ended March 2011 up 38.3% compared to prior fiscal year
-Cash and cash equivalents of $152.1 million at March 31, 2011 up from $79.2 million at March 31, 2010
-Adjusted EBITDA of $196.1 million for the fiscal year ended March 31, 2011
-GAAP net income per diluted share for the fourth quarter and fiscal year 2011 was $0.40, and $1.22, respectively
-Non-GAAP net income per diluted share for the fourth quarter and fiscal year 2011 was $0.49, and $2.22, respectively
GREENVILLE, S.C., May 12, 2011 /PRNewswire/ -- KEMET Corporation (NYSE: KEM) today reported preliminary results for the fourth fiscal quarter ended March 31, 2011. Net sales for the quarter ended March 31, 2011 were $261.5 million, which is a 22.8% increase over the same quarter last fiscal year.
On a U.S. GAAP basis, net income was $21.1 million, or $0.40 per diluted share for the fourth quarter of fiscal year 2011 compared to net income of $0.3 million or $0.01 per diluted share for the same quarter last year. The current fiscal quarter includes $2.0 million of restructuring charges primarily associated with the relocation of equipment, a $3.0 million inventory adjustment and $0.6 million of debt and stock registration related fees. The fourth quarter of fiscal year 2010 included $6.6 million of restructuring charges and a $1.5 million net gain on sales and disposals of assets.
Non-GAAP adjusted net income was $25.6 million or $0.49 per diluted share for the current fiscal quarter compared to a $6.8 million adjusted net income or $0.14 per diluted share for the same quarter last year.
"Our revenue remained strong and exceeded expectations in the last quarter of our year with revenue surpassing one billion dollars for our full fiscal year," said Per Loof, KEMET's Chief Executive Officer. "Our accomplishments on cost containment over the past year have continued to benefit our operating results and we expect that margins will hold in the near-term at or above our fourth quarter results despite rising raw material prices. We remain optimistic about the industry trend and demand for our products in all of our geographic regions and we remain focused on creating additional value as we begin our next fiscal year," continued Loof.
For the fiscal year ended March 31, 2011, net sales were $1,018.5 million up from $736.3 million in the prior fiscal year. On a U.S. GAAP basis, net income for the year was $63.0 million, or $1.22 per diluted share, compared to a net loss of $69.4 million, or $ (2.57) per share, for the fiscal year ended March 31, 2010. Non-GAAP net income was $114.2 million, or $2.22 per diluted share for the fiscal year ended March 31, 2011 compared to a net income of $2.6 million or $0.10 per diluted share for the fiscal year ended March 31, 2010.
About KEMET
The Company's common stock is listed on the NYSE under the ticker symbol 'KEM' (NYSE: KEM). At the Investor Relations section of our web site at http://www.KEMET.com/IR, users may subscribe to KEMET news releases and find additional information about our Company. KEMET applies world class service and quality to deliver industry leading, high performance capacitance solutions to its customers around the world and offers the world's most complete line of surface mount and through hole capacitor technologies across tantalum, ceramic, film, aluminum, electrolytic, and paper dielectrics. Additional information about KEMET can be found at http://www.kemet.com.
QUIET PERIOD
Beginning July 1, 2011, we will observe a quiet period during which the information provided in this news release and our annual report on Form 10-K will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.
CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS
Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about KEMET Corporation's (the "Company") financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates," variations of such words and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.
Factors that may cause actual outcome and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following:
(i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) adverse economic conditions could cause the write down of long-lived assets; (iii) an increase in the cost or a decrease in the availability of our principal raw materials; (iv) changes in the competitive environment; (v) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vi) economic, political, or regulatory changes in the countries in which we operate; (vii) difficulties, delays or unexpected costs in completing the restructuring plan; (viii) inability to attract, train and retain effective employees and management; (ix) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (x) exposure to claims alleging product defects; (xi) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xii) volatility of financial and credit markets affecting our access to capital; (xiii) needing to reduce the total costs of our products to remain competitive; (xiv) potential limitation on the use of net operating losses to offset possible future taxable income; (xv) exercise of the warrant by K Equity which could potentially may result in the existence of a significant stockholder who could seek to influence our corporate decisions; and (xvi) recent events in Japan could negatively impact our sales and supply chain.
Contact: |
William M. Lowe, Jr. |
Dean W. Dimke |
||
Executive Vice President and |
Director of Corporate and |
|||
Chief Financial Officer |
Investor Communications |
|||
864-963-6484 |
954-766-2800 |
|||
KEMET CORPORATION AND SUBSIDIARIES Consolidated Statements of Operations (Amounts in thousands except per share data) (Unaudited) |
||||||||||||
Quarters Ended |
Fiscal Years Ended |
|||||||||||
March 2011 |
March 2010 |
March 2011 |
March 2010 |
|||||||||
Net sales |
$ 261,452 |
$ 212,980 |
$ 1,018,488 |
$ 736,335 |
||||||||
Operating costs and expenses: |
||||||||||||
Cost of sales |
198,958 |
169,556 |
752,846 |
611,638 |
||||||||
Selling, general and administrative expenses |
27,940 |
25,388 |
104,607 |
86,085 |
||||||||
Research and development |
6,662 |
6,079 |
25,864 |
22,064 |
||||||||
Restructuring charges |
1,974 |
6,609 |
7,171 |
9,198 |
||||||||
Net (gain) loss on sales and disposals of assets |
145 |
(1,501) |
(1,261) |
(1,003) |
||||||||
Write down of long-lived assets |
- |
- |
- |
656 |
||||||||
Total operating costs and expenses |
235,679 |
206,131 |
889,227 |
728,638 |
||||||||
Operating income |
25,773 |
6,849 |
129,261 |
7,697 |
||||||||
Other (income) expense: |
||||||||||||
Interest income |
(85) |
(41) |
(218) |
(188) |
||||||||
Interest expense and amortization of debt discount |
7,627 |
6,264 |
30,175 |
26,008 |
||||||||
Other (income) expense, net |
(3,045) |
(2,078) |
(4,692) |
4,121 |
||||||||
(Gain) loss on early extinguishment of debt |
- |
- |
38,248 |
(38,921) |
||||||||
Increase in value of warrant |
- |
- |
- |
81,088 |
||||||||
Income (loss) before income taxes |
21,276 |
2,704 |
65,748 |
(64,411) |
||||||||
Income tax expense |
211 |
2,387 |
2,704 |
5,036 |
||||||||
Net income (loss) |
$ 21,065 |
$ 317 |
$ 63,044 |
$ (69,447) |
||||||||
Net income (loss) per share (basic) |
$ 0.57 |
$ 0.01 |
$ 2.11 |
$ (2.57) |
||||||||
Net income (loss) per share (diluted) |
$ 0.40 |
$ 0.01 |
$ 1.22 |
$ (2.57) |
||||||||
Weighted-average shares outstanding: |
||||||||||||
Basic |
37,127 |
27,017 |
29,847 |
26,971 |
||||||||
Diluted |
52,293 |
47,679 |
51,477 |
26,971 |
||||||||
KEMET CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (Amounts in thousands, except per share data) |
|||||||
March 31, |
|||||||
2011 |
2010 |
||||||
(Unaudited) |
|||||||
ASSETS |
|||||||
Current assets: |
|||||||
Cash and cash equivalents |
$ 152,051 |
$ 79,199 |
|||||
Accounts receivable, net |
160,708 |
137,385 |
|||||
Inventories, net |
206,440 |
150,508 |
|||||
Prepaid and other current assets |
18,020 |
18,790 |
|||||
Deferred income taxes |
5,301 |
2,129 |
|||||
Total current assets |
542,520 |
388,011 |
|||||
Property, plant and equipment, net |
310,412 |
319,878 |
|||||
Intangible assets, net |
20,092 |
21,806 |
|||||
Other assets |
11,285 |
11,266 |
|||||
Total assets |
$ 884,309 |
$ 740,961 |
|||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||
Current liabilities: |
|||||||
Current portion of long-term debt |
$ 42,101 |
$ 17,880 |
|||||
Accounts payable |
90,997 |
78,829 |
|||||
Accrued expenses |
88,291 |
63,606 |
|||||
Income taxes payable |
4,265 |
1,096 |
|||||
Total current liabilities |
225,654 |
161,411 |
|||||
Long-term debt |
231,215 |
231,629 |
|||||
Other non-current obligations |
59,727 |
55,626 |
|||||
Deferred income taxes |
7,960 |
8,023 |
|||||
Commitments and contingencies |
|||||||
Stockholders' equity: |
|||||||
Common stock, par value $0.01, authorized 300,000 shares, issued |
|||||||
39,508 and 29,508 shares at March 31, 2011 and 2010, respectively |
395 |
295 |
|||||
Additional paid-in capital |
479,322 |
479,705 |
|||||
Retained deficit |
(87,745) |
(150,789) |
|||||
Accumulated other comprehensive income |
22,555 |
11,990 |
|||||
Treasury stock, at cost (2,370 and 2,463 shares at March 31, 2011 |
|||||||
and 2010, respectively) |
(54,774) |
(56,929) |
|||||
Total stockholders' equity |
359,753 |
284,272 |
|||||
Total liabilities and stockholders' equity |
$ 884,309 |
$ 740,961 |
|||||
KEMET CORPORATION AND SUBSIDIARIES Consolidated Statements of Cash Flows (Amounts in thousands) (Unaudited) |
||||||||||||
Fiscal Years Ended March 31, |
||||||||||||
2011 |
2010 |
2009 |
||||||||||
Sources (uses) of cash and cash equivalents |
||||||||||||
Operating activities: |
||||||||||||
Net income (loss) |
$ 63,044 |
$ (69,447) |
$ (285,209) |
|||||||||
Adjustments to reconcile net income (loss) to net cash provided by |
||||||||||||
operating activities: |
||||||||||||
Depreciation and amortization |
52,932 |
52,644 |
58,125 |
|||||||||
Amortization of debt discount and debt issuance costs |
4,930 |
13,392 |
9,918 |
|||||||||
Net gain on sales and disposals of assets |
(1,261) |
(1,003) |
(25,505) |
|||||||||
Stock-based compensation expense |
1,783 |
1,865 |
1,070 |
|||||||||
Pension and other post-retirement benefits |
(2,319) |
(2,716) |
(3,742) |
|||||||||
Deferred income taxes |
(3,403) |
2,051 |
(8,146) |
|||||||||
(Gain) loss on early extinguishment of debt |
38,248 |
(38,921) |
- |
|||||||||
Write down of long-lived assets |
- |
656 |
67,624 |
|||||||||
Goodwill impairment |
- |
- |
174,327 |
|||||||||
Increase in value of warrant |
- |
81,088 |
- |
|||||||||
Curtailment gains on benefit plans |
- |
- |
(30,835) |
|||||||||
Other, net |
(2,446) |
339 |
- |
|||||||||
Changes in assets and liabilities: |
||||||||||||
Accounts receivable |
(14,466) |
(18,263) |
44,777 |
|||||||||
Inventories |
(48,817) |
7,168 |
71,308 |
|||||||||
Prepaid expenses and other current assets |
(6,647) |
(5,647) |
4,055 |
|||||||||
Accounts payable |
9,567 |
26,605 |
(67,356) |
|||||||||
Accrued income taxes |
4,315 |
421 |
(490) |
|||||||||
Other operating liabilities |
18,508 |
4,388 |
(4,196) |
|||||||||
Net cash provided by operating activities |
113,968 |
54,620 |
5,725 |
|||||||||
Investing activities: |
||||||||||||
Capital expenditures |
(34,989) |
(12,921) |
(30,541) |
|||||||||
Proceeds from sales of assets |
5,425 |
1,500 |
34,870 |
|||||||||
Acquisitions, net of cash received |
- |
- |
(1,000) |
|||||||||
Change in restricted cash |
- |
- |
3,900 |
|||||||||
Net cash provided by (used in) investing activities |
(29,564) |
(11,421) |
7,229 |
|||||||||
Financing activities: |
||||||||||||
Proceeds from issuance of debt |
227,525 |
58,949 |
16,190 |
|||||||||
Payment of long-term debt |
(230,413) |
(54,525) |
(67,949) |
|||||||||
Net (payments) borrowings under other credit facilities |
(2,479) |
475 |
(411) |
|||||||||
Debt issuance costs |
(7,853) |
(4,206) |
(1,574) |
|||||||||
Debt extinguishment costs |
(207) |
(3,605) |
- |
|||||||||
Proceeds from exercise of stock options |
89 |
- |
- |
|||||||||
Other |
- |
- |
249 |
|||||||||
Net cash used in financing activities |
(13,338) |
(2,912) |
(53,495) |
|||||||||
Net increase (decrease) in cash and cash equivalents |
71,066 |
40,287 |
(40,541) |
|||||||||
Effect of foreign currency fluctuations on cash |
1,786 |
(292) |
(1,638) |
|||||||||
Cash and cash equivalents at beginning of fiscal year |
79,199 |
39,204 |
81,383 |
|||||||||
Cash and cash equivalents at end of fiscal year |
$ 152,051 |
$ 79,199 |
$ 39,204 |
|||||||||
Non-U.S. GAAP Financial Measures
In this news release, the Company makes reference to certain Non-U.S. GAAP financial measures, including "Adjusted net income", "Adjusted net income per share" and "Adjusted EBITDA". Management believes that investors may find it useful to review the Company's financial results as adjusted to exclude items as determined by management.
Adjusted Net Income and Adjusted Net Income Per Share
"Adjusted net income" and "Adjusted net income per share" represent net income/loss and net income/loss per share excluding increase in value of warrant, gain/loss on early extinguishment of debt, ERP integration costs, restructuring charges related primarily to equipment moves and employee severance, gain/loss on sales and disposals of assets, amortization related to debt issuance costs and debt discount, debt and stock registration related fees, cancellation of incentive plan, write down of long-lived assets, net foreign exchange gain/loss, stock-based compensation expense, write off of capitalized advisor fee and gain on licensing of patents. Management believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company. Management uses these Non-U.S. GAAP financial measures to evaluate operating performance. Non-U.S. GAAP financial measures should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.
The following table provides reconciliation from U.S. GAAP net income/loss to Non-U.S. GAAP adjusted net income/loss:
GAAP to Non-GAAP Reconciliation |
||||||||||||
(Unaudited) |
Quarters Ended |
Fiscal Years Ended |
||||||||||
March 2011 |
December 2010 |
March 2010 |
March 2011 |
March 2010 |
||||||||
(Amounts in thousands, except per share data) |
||||||||||||
Including adjustments (GAAP) |
||||||||||||
Net sales |
$ 261,452 |
$ 264,654 |
$ 212,980 |
$ 1,018,488 |
$ 736,335 |
|||||||
Net income (loss) |
$ 21,065 |
$ 27,167 |
$ 317 |
$ 63,044 |
$ (69,447) |
|||||||
Net income (loss) per share (basic) |
$ 0.57 |
$ 0.96 |
$ 0.01 |
$ 2.11 |
$ (2.57) |
|||||||
Net income (loss) per share (diluted) |
$ 0.40 |
$ 0.52 |
$ 0.01 |
$ 1.22 |
$ (2.57) |
|||||||
Excluding the following items (Non-GAAP) |
||||||||||||
Net income (loss) |
$ 21,065 |
$ 27,167 |
$ 317 |
$ 63,044 |
$ (69,447) |
|||||||
Adjustments: |
||||||||||||
Restructuring charges |
1,974 |
1,102 |
6,609 |
7,171 |
9,198 |
|||||||
Net foreign exchange (gain) loss |
(3,266) |
1,785 |
(2,093) |
(2,888) |
4,106 |
|||||||
Inventory write-downs |
2,991 |
- |
- |
2,991 |
- |
|||||||
Amortization included in interest expense |
966 |
1,210 |
3,806 |
4,930 |
13,392 |
|||||||
Stock-based compensation expense |
872 |
429 |
77 |
1,783 |
1,865 |
|||||||
ERP integration costs |
658 |
602 |
- |
1,915 |
- |
|||||||
Debt and stock registration related fees |
581 |
950 |
- |
1,531 |
- |
|||||||
(Gain) loss on sales and disposals of assets |
145 |
29 |
(1,501) |
(1,261) |
(1,003) |
|||||||
(Gain) loss on early extinguishment of debt |
- |
- |
- |
38,248 |
(38,921) |
|||||||
Gain on licensing of patents |
- |
- |
- |
(2,000) |
- |
|||||||
Increase in value of warrant |
- |
- |
- |
- |
81,088 |
|||||||
Charge related to cancellation of an incentive plan |
- |
- |
- |
- |
1,161 |
|||||||
Write down of long lived assets |
- |
- |
- |
- |
656 |
|||||||
Write off of capitalized advisor fees |
- |
- |
- |
- |
413 |
|||||||
Income tax effect of non-GAAP adjustments (2) |
(428) |
(196) |
(462) |
(1,256) |
65 |
|||||||
Adjusted net income (excluding adjustments) |
$ 25,558 |
$ 33,078 |
$ 6,753 |
$ 114,208 |
$ 2,573 |
|||||||
Adjusted net income per basic |
||||||||||||
share (excluding adjustments) |
$ 0.69 |
$ 1.17 |
$ 0.25 |
$ 3.83 |
$ 0.10 |
|||||||
Adjusted net income per diluted |
||||||||||||
share (excluding adjustments) |
$ 0.49 |
$ 0.64 |
$ 0.14 |
$ 2.22 |
$ 0.10 |
|||||||
(1) The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction. |
|
Adjusted EBITDA-
Adjusted EBITDA represents net income/loss before income tax expense, net interest expense, and depreciation and amortization expense, adjusted to exclude: restructuring charges, stock-based compensation expense, debt and stock registration related fees, gain/loss on sales and disposals of assets, write down of long-lived assets, gain/loss on early extinguishment of debt, ERP integration costs, net foreign exchange gain/loss, inventory write-downs, increase in value of warrant and gain on licensing of patents. We use Adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business. We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt. We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.
We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other items excluded from Adjusted EBITDA are excluded in order to better reflect our continuing operations.
In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments. Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.
Our Adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:
- it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
- it does not reflect changes in, or cash requirements for, our working capital needs;
- it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;
- although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements;
- it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
- it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;
- it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and
- other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.
Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.
The following tables provide reconciliation from U.S. GAAP net income (loss) to Adjusted EBITDA (amounts in thousands):
Fiscal Year 2011 |
|||||||
Q1 |
Q2 |
Q3 |
Q4 |
Total |
|||
Net income (loss) |
$ (20,099) |
$ 34,911 |
$ 27,167 |
$ 21,065 |
$ 63,044 |
||
Income tax expense |
1,275 |
593 |
625 |
211 |
2,704 |
||
Interest expense, net |
7,437 |
7,250 |
7,728 |
7,542 |
29,957 |
||
Depreciation and amortization expense |
14,510 |
14,132 |
12,661 |
11,629 |
52,932 |
||
Stock-based compensation expense |
149 |
333 |
429 |
872 |
1,783 |
||
Net foreign exchange (gain) loss |
1,272 |
(2,679) |
1,785 |
(3,266) |
(2,888) |
||
ERP integration costs |
280 |
375 |
602 |
658 |
1,915 |
||
(Gain) loss on sales and disposals of assets |
335 |
(1,770) |
29 |
145 |
(1,261) |
||
Restructuring charges |
1,792 |
2,303 |
1,102 |
1,974 |
7,171 |
||
Loss on early extinguishment of debt |
38,248 |
- |
- |
- |
38,248 |
||
Gain on licensing of patents |
- |
(2,000) |
- |
- |
(2,000) |
||
Debt and stock registration related fees |
- |
- |
950 |
581 |
1,531 |
||
Inventory write-downs |
- |
- |
- |
2,991 |
2,991 |
||
Adjusted EBITDA |
$ 45,199 |
$ 53,448 |
$ 53,078 |
$ 44,402 |
$ 196,127 |
||
Fiscal Year 2010 |
|||||||
Q1 |
Q2 |
Q3 |
Q4 |
Total |
|||
Net income (loss) |
$ 25,090 |
$ (93,075) |
$ (1,779) |
$ 317 |
$ (69,447) |
||
Income tax expense (benefit) |
1,030 |
1,712 |
(93) |
2,387 |
5,036 |
||
Interest expense, net |
5,788 |
6,389 |
7,420 |
6,223 |
25,820 |
||
Depreciation and amortization expense |
12,264 |
13,226 |
13,701 |
13,453 |
52,644 |
||
Gain on early extinguishment of debt |
(38,921) |
- |
- |
- |
(38,921) |
||
Stock-based compensation expense |
241 |
1,379 |
168 |
77 |
1,865 |
||
(Gain) loss on sales and disposals of assets |
206 |
52 |
240 |
(1,501) |
(1,003) |
||
Net foreign exchange (gain) loss |
4,221 |
1,416 |
562 |
(2,093) |
4,106 |
||
Restructuring charges |
- |
1,267 |
1,322 |
6,609 |
9,198 |
||
Increase in value of warrant |
- |
81,088 |
- |
- |
81,088 |
||
Write down of long-lived assets |
- |
- |
656 |
- |
656 |
||
Adjusted EBITDA |
$ 9,919 |
$ 13,454 |
$ 22,197 |
$ 25,472 |
$ 71,042 |
||
SOURCE KEMET Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article